Nevertheless, some studies [22] implied that specific mutations, for example, the BRCA2 exon 11 mutation, increase the incidence of colorectal, stomach and pancreatic cancers more than other mutations. This evidence concerns the gene BRCA2 and pancreatic neoplasm.